跳至主要内容
临床试验/NCT03072459
NCT03072459已完成不适用

A Retrospective Study of the Navio™ Robotic-assisted Surgical System

Smith & Nephew, Inc.5 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2017年7月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
128
试验地点
5
主要终点
Evaluate the Navio™ System for Revisions at 2+ Years Post-surgical Implantation Survivorship

研究概览

简要总结

A retrospective, multi-center, cohort study with prospective follow-up and comparison to historical control

详细描述

Subjects who had previously received the Navio robotic-assisted surgical system for unilateral knee replacement (UKR) were assessed to determine the 2-year safety and effectiveness of the Navio system.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female subjects ≥ 18 years old (at the time of surgery) who have undergone Navio System-assisted UKR at least 2 years prior to enrollment. This includes UKR procedures with all Unicondylar Knee cemented implant designs.
  • Subject had a primary diagnosis of unicompartmental, non-inflammatory degenerative joint disease including osteoarthritis, traumatic arthritis, or avascular necrosis, required correction of functional deformity, or required treatment of fractures that were unmanageable using other techniques.

排除标准

  • Subject received the Navio System-assisted UKR on the index joint as a revision for a previously failed UKR.
  • Subject, in the opinion of the Investigator, had advanced osteoarthritis or joint disease at the time of surgery and was better suited for Total Knee Arthroplasty (TKA).
  • Subject, in the opinion of the Investigator, had a neuromuscular disorder that prohibited control of the index joint.
  • Subject, in the opinion of the Investigator, was morbidly obese.
  • Subject, in the opinion of the Investigator, was contraindicated for UKR.
  • Subject (prospective subjects only), in the opinion of the Investigator, has an emotional or neurological condition including mental illness, mental retardation, drug or alcohol abuse.
  • Subject (prospective subjects only) is a prisoner.

结局指标

主要结局

Evaluate the Navio™ System for Revisions at 2+ Years Post-surgical Implantation Survivorship

时间窗: Preoperative (Baseline) and 24, 48, 72, 96, and 120 weeks postoperatively

Analysis of the absence of device revision (overall survivorship) outcomes assessed from Baseline through 120 weeks post-surgical implantation.

次要结局

  • Evaluation of Efficacy Based on Veterans RAND 12 (VR-12) Assessments(Preoperative (Baseline) and 6, 12, 18, 24, 30, and 36 months postoperatively)
  • Postoperative 24-Month Evaluation of Efficacy Based on Radiographic Findings(24 months postoperatively)
  • Postoperative 12-Month Evaluation of Efficacy Based on Radiographic Findings(12 months postoperatively)
  • Postoperative 18-Month Evaluation of Efficacy Based on Radiographic Findings(18 months postoperatively)
  • Preoperative Evaluation of Efficacy Based on Radiographic Findings(Preoperative (Baseline))
  • Postoperative 6-Month Evaluation of Efficacy Based on Radiographic Findings(6 months postoperatively)
  • Evaluation of Efficacy Based on Knee Society Score (KSS) Assessments(Preoperative (Baseline) and 6, 12, 18, 24, 30, and 36 months postoperatively)
  • Postoperative 30-Month Evaluation of Efficacy Based on Radiographic Findings(30 months postoperatively)
  • Postoperative 36-Month Evaluation of Efficacy Based on Radiographic Findings(36 months postoperatively)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验